Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Arcutis Biotherapeutics Inc., 3 years.
Arcutis Biotherapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Arcutis Biotherapeutics Inc. June 5, 202680.4%
-
Arcutis Biotherapeutics Inc. June 2, 202398.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Arcutis Biotherapeutics Inc. | Grant or award | +5,778 | — | — |
| Nov 15, 2025 | Artiva Biotherapeutics Inc. | Shares withheld for tax | −3,490 | $3.25 | $11,343 |
| Nov 13, 2025 | Arcutis Biotherapeutics Inc. | Option exercise | +27,052 | $8.63 | $233,459 |
| Nov 13, 2025 | Arcutis Biotherapeutics Inc. | Option exercise | +12,220 | $7.51 | $91,772 |
| Nov 13, 2025 | Arcutis Biotherapeutics Inc. | Open-market sale | −39,272 | $23.19 | $910,718 |
| Nov 13, 2025 | Arcutis Biotherapeutics Inc. | Open-market sale | −1,232 | $23.37 | $28,792 |
| Aug 15, 2025 | Artiva Biotherapeutics Inc. | Shares withheld for tax | −5,813 | $2.75 | $15,986 |
| Jun 12, 2025 | Arcutis Biotherapeutics Inc. | Grant or award | +7,609 | — | — |
| May 15, 2025 | Artiva Biotherapeutics Inc. | Shares withheld for tax | −1,341 | $2.13 | $2,856 |
| Feb 26, 2025 | Artiva Biotherapeutics Inc. | Grant or award | +60,000 | — | — |
| Sep 12, 2024 | Artiva Biotherapeutics Inc. | Grant or award | +50,000 | — | — |
| Jun 14, 2024 | Arcutis Biotherapeutics Inc. | Grant or award | +10,139 | — | — |
| May 31, 2023 | Arcutis Biotherapeutics Inc. | Grant or award | +4,375 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.